Neuly
Madison, Wisconsin, USA
University of Minnesota
Saint Paul, Minnesota, USA
Research
California Institute of Integral Studies
San Francisco, California, USA
Naropa University
Boulder, Colorado, USA
Explorer Equity Group
California Center for Psychedelic Therapy
Los Angeles, California, USA
Baylor College of Medicine
Houston, Texas, USA
Matter Academy
New York, New York, USA
Innerwell
Remote
Peak
Johns Hopkins, Center for Psychedelic & Consciousness Research
Baltimore, Maryland, USA
Cerebral
Therapy
Washington, USA
Arizona, USA
Hawaii, USA
McGill University
Montreal, Quebec, Canada
Psilocybin • Ketamine • Therapy • Research • Psychedelics
Ketamine
Small Pharma
Manchester, England, United Kingdom
Delix Therapeutics
Boston, Massachusetts, USA
Gilgamesh Pharmaceutical
Usona Institute
Madison, Wisconsin, USA • Remote
Cybin
New Jersey, USA
Numinus
Vancouver, British Columbia, Canada
COMPASS Pathways
New York, New York, USA • San Francisco, California, USA • London, England, United Kingdom • Remote
Allen Institute
Seattle, Washington, USA
Berkeley Center for the Science of Psychedelics (BCSP)
Berkeley, California, USA
PRISMATICS
Psychedelic Science Funders Collaborative
Transcend Therapeutics
Voyage Healing of Philadelphia
Philadelphia, Pennsylvania, USA
Psychae Institute
Melbourne, Victoria, Australia
King’s College London
London, England, United Kingdom
Mindbloom
Mimosa Therapeutics
Amsterdam, North Holland, Netherlands
Centre for Compassionate Care (C3)
Hamilton, Ontario, Canada
The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School
Cambridge, Massachusetts, USA
Clerkenwell Health
United Kingdom • Remote
MagicMed Industries
Calgary, Alberta, Canada
atai Life Sciences
New York City, New York, USA • Remote
Tryp Therapeutics
San Diego, California, USA
MAPS
California, USA • Remote
Noetic Foundry
Sage Institute
Apollo Neuro
Pittsburgh, Pennsylvania, USA
Powered by